Differential immunogenicity of homologous versus heterologous boost in Ad26.COV2.S vaccine recipients | medRxiv
Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study - The Lancet
![Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults ...](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7113e2_JJBoosterVE_IMAGE_29March22_1200x675.jpg?_=89755 "Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults ...")
Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults ...
Homologous and Heterologous Covid-19 Booster Vaccinations | NEJM
RACGP - Does mixing COVID boosters provide better immunity?
Safety of heterologous primary and booster schedules with ChAdOx1-S and BNT162b2 or mRNA-1273 vaccines: nationwide cohort study | The BMJ
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial - The Lancet
Govt panel likely to decide on Covovax as a heterologous booster dose for adults on Wednesday, ET HealthWorld
Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study - The Lancet Global Health
Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters
What is a heterologous booster COVID vaccine, and why should you take this jab?, ET HealthWorld
Heterologous booster schedules are associated with increased protection against severe, omicron related COVID-19 outcomes
Comparative effectiveness of heterologous third dose vaccine schedules against severe covid-19 during omicron predominance in Nordic countries: population based cohort analyses | The BMJ
Heterologous booster response after inactivated virus BBIBP-CorV vaccination in older people - The Lancet Infectious Diseases
Heterologous COVID-19 booster doses show 68 percent effectiveness
iNCOVACC World's first Intranasal Vaccine to receive both Primary series & Heterologous booster approval | DD News
Covovax booster dose: DGCI approves Covid-19 vaccine Covovax as heterologous booster dose - The Economic Times
Corbevax gets DCGI nod as heterologous Covid booster dose for adults | Mint
Effectiveness of Homologous or Heterologous Covid-19 Boosters in Veterans | NEJM
Explained | What is a heterologous booster vaccine, and what are its advantages? - The Hindu
NTAGI holds meeting on Covovax inclusion as heterologous booster on CoWin portal, ET HealthWorld
Protection of homologous and heterologous boosters after primary schemes of rAd26-rAd5, ChAdOx1 nCoV-19 and BBIBP-CorV during the omicron outbreak in adults of 50 years and older in Argentina: a test-negative case–control study -
